Literature DB >> 27426482

Getting cytisine licensed for use world-wide: a call to action.

Natalie Walker1, Chris Bullen2, Joanne Barnes3, Hayden McRobbie4, Piotr Tutka5, Martin Raw6, Jean-François Etter7, Kamran Siddiqi8, Ryan J Courtney9, João Mauricio Castaldelli-Maia10, Peter Selby11, Janie Sheridan12, Nancy A Rigotti13.   

Abstract

Keywords:  Affordable; cost-effective; cytisine; regulatory approval; smoking cessation; treatment

Mesh：

Substances：

Year:  2016        PMID： 27426482     DOI： 10.1111/add.13464

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  8 in total

1.  Cytisine for smoking cessation.

Authors:  Taleen Karnieg; Xiang Wang
Journal:  CMAJ       Date:  2018-05-14       Impact factor: 8.262

2.  Cytisine inhibits the protective activity of various classical and novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice.

Authors:  Piotr Tutka; Maria W Kondrat-Wróbel; Katarzyna Zaluska; Dorota Żółkowska; Magdalena Florek-Łuszczki; Jarogniew J Łuszczki
Journal:  Psychopharmacology (Berl)       Date:  2016-10-25       Impact factor: 4.530

Review 3.  The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.

Authors:  Hans Rollema; Raymond S Hurst
Journal:  Psychopharmacology (Berl)       Date:  2018-07-07       Impact factor: 4.530

Review 4.  Discovery and development of varenicline for smoking cessation.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Expert Opin Drug Discov       Date:  2018-03-28       Impact factor: 6.098

5.  Progress in implementation of WHO FCTC Article 14 and its guidelines: a survey of tobacco dependence treatment provision in 142 countries.

Authors:  Kapka Nilan; Martin Raw; Tricia M McKeever; Rachael L Murray; Ann McNeill
Journal:  Addiction       Date:  2017-08-02       Impact factor: 6.526

Review 6.  Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG.

Authors:  O C P Van Schayck; S Williams; V Barchilon; N Baxter; M Jawad; P A Katsaounou; B J Kirenga; C Panaitescu; I G Tsiligianni; N Zwar; A Ostrem
Journal:  NPJ Prim Care Respir Med       Date:  2017-06-09       Impact factor: 2.871

7.  The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial.

Authors:  Omara Dogar; Deepa Barua; Melanie Boeckmann; Helen Elsey; Razia Fatima; Rhian Gabe; Rumana Huque; Ada Keding; Amina Khan; Daniel Kotz; Eva Kralikova; James N Newell; Iveta Nohavova; Steve Parrott; Anne Readshaw; Lottie Renwick; Aziz Sheikh; Kamran Siddiqi
Journal:  Addiction       Date:  2018-04-20       Impact factor: 6.526

8.  Determination of Cytisine and N-Methylcytisine from Selected Plant Extracts by High-Performance Liquid Chromatography and Comparison of Their Cytotoxic Activity.

Authors:  Anna Petruczynik; Karol Wróblewski; Justyna Misiurek; Tomasz Plech; Karolina Szalast; Krzysztof Wojtanowski; Tomasz Mroczek; Grażyna Szymczak; Monika Waksmundzka-Hajnos; Piotr Tutka
Journal:  Toxins (Basel)       Date:  2020-08-29       Impact factor: 4.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.